AVITA Medical Q3 EPS $(0.20) Beats $(0.22) Estimate, Sales $25.862M Beat $22.200M Estimate
Benzinga Newsdesk 18 hours ago
NewsEarningsEarnings Beats
AVITA Medical (NASDAQ:RCEL) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.22) by 9.09 percent. This is a 56.52 percent increase over losses of $(0.46) per share from the
AVITA Medical (NASDAQ:RCEL) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.22) by 9.09 percent. This is a 56.52 percent increase over losses of $(0.46) per share from the same period last year. The company reported quarterly sales of $25.862 million which beat the analyst consensus estimate of $22.200 million by 16.50 percent. This is a 53.06 percent increase over sales of $16.897 million the same period last year.